In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on human fibrosarcoma cells HT-1080
- 76 Downloads
Current treatment of fibrosarcoma, an aggressive cancer of the connective tissue, is generally associated with poor prognosis. Matrix metalloproteinases (MMPs), vascular endothelial growth factor (VEGF), and constituents of the extracellular matrix (ECM), such as fibronectin, play a critical role in angiogenesis and underlie neoplastic invasion and metastasis. This and anticancer properties of lysine, proline, arginine, ascorbic acid, and green tea extract (NM) prompted us to investigate the effect of these nutrients in vitro on human fibrosarcoma cells HT-1080 by measuring cell proliferation, modulation of MMP-2 and MMP-9, and invasive potential. In vivo, we studied the growth of human fibrosarcoma HT-1080 cells in athymic nude mice and the expression of MMPs and VEGF. Cell proliferation was evaluated by MTT assay, MMP expression by gelatinase zymography, and invasion through Matrigel and migration by scratch assay. Tumors were excised, weighed, and processed for histology in both the control and nutrient-supplemented groups. Results showed NM inhibited the growth and reduced the size of tumors in nude mice; decreased MMP-9 and VEGF secretion was found in the suplemented group tissues. NM inhibited invasion through Matrigel and migration with total inhibition at 1000 μg/mL. These results offer promise in the therapeutic use of the nutrient mixture of lysine, proline, arginine, ascorbic acid, and green tea extract tested in the treatment of fibrosarcoma.
Key wordsFibrosarcoma xenograft nude mice green tea extract ascorbic acid lysine proline antitumor effect MMP-9 Matrigel invasion
Unable to display preview. Download preview PDF.
- 5.(2003, February 12). “Childhood Soft Tissue Sarcoma (PDQ®). Treatment”. National Cancer Institute. http://www.nci.nih.gov/cancerinfo/pdq/treatment/child-soft-tissue-sarcoma/patient (1 Feb. 2004).Google Scholar
- 7.Rath M, Pauling L. Plasmin-induced proteolysis and the role of apoprotein(a), lysine and synthetic analogs. Orthomolecular Medicine 1992; 7: 7–23.Google Scholar
- 8.Netke SP, Roomi MW, Ivanov V, Niedzwiecki A, Rath M. A specific combination of ascorbic acid, lysine, proline and epigallocatechin gallate inhibits proliferation and extracellular matrix invasion of various human cancer cell lines. Research Communications in Pharmacology and Toxicology: Emerging Drugs 2003; 2: 37–50.Google Scholar
- 9.Roomi MW, Ivanov V, Niedzwiecki A, Rath M. Inhibition of tumor growth of human breast, prostate, colon, melanoma, fibrosarcoma and synovial sarcoma cancer xenografts by nutrient synergy in nude mice. Presented at American Society for Cell Biology Meeting, San Francisco, CA, December, 2003.Google Scholar
- 13.Fang W, Li H, Kong L, et al. Role of matrix metalloproteinases (MMPs) in tumor invasion and metastasis: serial studies on MMPs and TIMPs. Bejing D Xue Bao 2003; 4: 441–443.Google Scholar
- 16.Nunez C, Ortiz de Apodaca Y, Ruiz A. Ascorbic acid in the plasma and blood cells of women with breast cancer. The effect of consumption of food with an elevated content of this vitamin. Nutr Hosp 1995; 10: 368–372.Google Scholar
- 20.Maeda-Yamamoto M, Suzuki N, Sawai Y, et al. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. J Agric Food Chem 2003; 51(7): 1858–1863.PubMedCrossRefGoogle Scholar